Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 98 hits in this display
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
Ki: 5.50E+3nMAssay Description:Inhibition of human AKR1C3 expressed in Escherichia coli incubated for 30 mins in presence of NADPH regeneration system by UHPLC analysisMore data for this Ligand-Target Pair
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
Cdc2(Asterina pectinifera)University Of California
Curated by ChEMBL
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
IC50: 70nMpH: 7.5 T: 2°CAssay Description:In vitro kinase assay using purified enzyme, was incubated at 30 °C with substrate, and test compounds in the presence of 15 uM ATP/ [gamma-33P]...More data for this Ligand-Target Pair
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
IC50: 75nMpH: 7.5 T: 2°CAssay Description:In vitro kinase assay using purified enzyme, was incubated at 30 °C with substrate, and test compounds in the presence of 15 uM ATP/ [gamma-33P]...More data for this Ligand-Target Pair
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
IC50: 240nMpH: 7.4 T: 2°CAssay Description:Inhibition of human Src kinase activity by ARIAD compounds were measured in a homogeneous time-resolved fluorescence resonance energy transfer (TR-FR...More data for this Ligand-Target Pair
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM50093397((R){1-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-pur...)
Cdc2(Asterina pectinifera)University Of California
Curated by ChEMBL
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
IC50: 1.59E+3nMpH: 7.4 T: 2°CAssay Description:Inhibition of human Src kinase activity by ARIAD compounds were measured in a homogeneous time-resolved fluorescence resonance energy transfer (TR-FR...More data for this Ligand-Target Pair
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
IC50: 2.00E+3nMAssay Description:Inhibition of yeast W303 Pho85 phosphorylation assessed as [32P] incorporation in histone H1 from [gamma32P]ATP by scintillation countingMore data for this Ligand-Target Pair
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
IC50: 6.58E+3nMAssay Description:Inhibition of human AKR1C3 expressed in Escherichia coli incubated for 30 mins in presence of NADPH regeneration system by UHPLC analysisMore data for this Ligand-Target Pair
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
IC50: 7.00E+3nMAssay Description:Inhibition of yeast W303 cdc28 phosphorylation assessed as [32P] incorporation in histone H1 from [gamma32P]ATP by scintillation countingMore data for this Ligand-Target Pair
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM50132193(2-[8-Chloro-6-(3-chloro-phenylamino)-9-isopropyl-9...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM50113680((R)-2-(6-(3-chlorophenylamino)-9-isopropyl-9H-puri...)
BDBM50113682(3-[[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-...)
IC50: >2.00E+4nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBMRI, San Diego CA...More data for this Ligand-Target Pair
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM50154615(2-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM50113684(2-[6-(4-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM27216((2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM50113729(2-[[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-...)
BDBM50113682(3-[[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-...)
BDBM50113747(2-(9-Isopropyl-6-phenylamino-9H-purin-2-ylamino)-3...)
BDBM50113680((R)-2-(6-(3-chlorophenylamino)-9-isopropyl-9H-puri...)
BDBM50113749(2-[6-(3-Chloro-4-fluoro-phenylamino)-9-isopropyl-9...)
BDBM50113728(CHEMBL305823 | {1-[6-(3-Chloro-phenylamino)-9-isop...)
BDBM50113746(2-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
IC50: >5.00E+5nMAssay Description:Inhibition of yeast W303 Cak1 phosphorylation assessed as [32P] incorporation in histone H1 from [gamma32P]ATP by scintillation countingMore data for this Ligand-Target Pair
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
IC50: >5.00E+5nMAssay Description:Inhibition of yeast W303 Kin28 phosphorylation assessed as [32P] incorporation in histone H1 from [gamma32P]ATP by scintillation countingMore data for this Ligand-Target Pair
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
IC50: >5.00E+5nMAssay Description:Inhibition of yeast W303 Srb10 phosphorylation assessed as [32P] incorporation in histone H1 from [gamma32P]ATP by scintillation countingMore data for this Ligand-Target Pair
BDBM50113704(2-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM50113696(2-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM50093397((R){1-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-pur...)
BDBM50113745(3-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM50113752(2-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM50113717(2-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM50113701(2-{[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-...)
BDBM50113681(2-{[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-...)
BDBM50113730(2-[6-(4-Amino-3-chloro-phenylamino)-9-isopropyl-9H...)
BDBM50113693(2-[6-(3-Amino-4-chloro-phenylamino)-9-isopropyl-9H...)
BDBM50235040(AMINOPURVALANOL | CHEBI:38937)
BDBM50113707(2,6,9-Trisubstitute purine, 2 | 2-(2-hydroxyethyla...)
BDBM50113745(3-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM50113680((R)-2-(6-(3-chlorophenylamino)-9-isopropyl-9H-puri...)
EC50: 2.49E+3nMAssay Description:Keywords: STK33 Kinase, Non-ATP Competitive Inhibitor Assay Overview: Purified STK33 Kinase is preincubated with potential inhibitors and allowed to ...More data for this Ligand-Target Pair
BDBM50113682(3-[[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-...)
EC50: 2.86E+3nMAssay Description:Keywords: STK33 Kinase, Non-ATP Competitive Inhibitor Assay Overview: Purified STK33 Kinase is preincubated with potential inhibitors and allowed to ...More data for this Ligand-Target Pair
BDBM50113745(3-[6-(3-Chloro-phenylamino)-9-isopropyl-9H-purin-2...)
BDBM50113680((R)-2-(6-(3-chlorophenylamino)-9-isopropyl-9H-puri...)
BDBM50113680((R)-2-(6-(3-chlorophenylamino)-9-isopropyl-9H-puri...)
Displayed 1 to 50 (of 98 total ) | Next | Last >>